Journal of Ophthalmology

Optical Coherence Tomography Biomarkers and Where to Find Them


Publishing date
01 Feb 2021
Status
Closed
Submission deadline
18 Sep 2020

Lead Editor

1A.S.L. TO5, Chieri, Italy

2University of Milan, Milan, Italy

3Institut de la Vision, Paris, France

4Hôpital Lariboisière - Université de Paris, Paris, France

This issue is now closed for submissions.

Optical Coherence Tomography Biomarkers and Where to Find Them

This issue is now closed for submissions.

Description

In an era of new therapeutic developments, predicting the incidence and the progression of retinal diseases, as well as their response to treatment, represents one of the main challenges in clinical research. As a result, the use of biomarkers as selection criteria and as surrogate endpoints in clinical trials has become crucial. However, the bottleneck is the validity of those markers in terms of availability, reproducibility, accuracy, and clinical relevance. Hence, multiple validation studies, enrolling large cohorts of patients are warranted.

Over the last two decades, the availability of optical coherence tomography (OCT) has dramatically transformed our knowledge, especially for retinal diseases. OCT uses infrared light (with high penetration properties) to measure different backscatters from biological tissues, yielding micrometre-resolution images. OCT angiography (OCTA) is another promising and rapidly evolving technology that allows visualising the flow within the retina in a depth-resolved fashion. The possibility of studying the retina in three dimensions, low dependence on the operator’s skills, the lack of need for intravenous dye, and the high-resolution of the resultant images are major advantages of these techniques. Both of these are now available in most clinical settings and routinely performed in clinical practice to assess patients with retinal disorders. For all these reasons, OCT and OCTA constitute ideal imaging techniques for the development and validation of new biomarkers for the diagnosis, assessment, and prognosis of retinal diseases.

In this Special Issue, we welcome original research or review articles related to the identification and/or validation of OCT and OCTA biomarkers in retinal diseases, ranging from age-related macular degeneration to retinal vascular diseases, uveitis, and inherited retinal dystrophies.

Potential topics include but are not limited to the following:

  • Optical coherence tomography
  • Optical coherence tomography angiography
  • Biomarkers
  • Age-related macular degeneration
  • Inherited Retinal dystrophies
  • Retinal vascular diseases
  • Uveitis

Articles

  • Special Issue
  • - Volume 2021
  • - Article ID 8844614
  • - Review Article

Optical Coherence Tomography Imaging of the Lamina Cribrosa: Structural Biomarkers in Nonglaucomatous Diseases

Alice Paulo | Pedro G. Vaz | ... | João Barbosa Breda
  • Special Issue
  • - Volume 2021
  • - Article ID 8871602
  • - Research Article

Discordance in Retinal and Choroidal Vascular Densities in Patients with Type 2 Diabetes Mellitus on Optical Coherence Tomography Angiography

Ho Ra | Nam Yeo Kang | ... | Jiwon Baek
  • Special Issue
  • - Volume 2020
  • - Article ID 8869455
  • - Research Article

Spectral-Domain Optical Coherence Tomography-Based Morphofunctional Characterization of Dome-Shaped Maculopathy in Indian Population

Naresh Babu Kannan | Sagnik Sen | ... | Kim Ramasamy
  • Special Issue
  • - Volume 2020
  • - Article ID 9861086
  • - Research Article

Novel Optical Coherence Tomography Parameters as Prognostic Factors for Stage 3 Epiretinal Membranes

Young Gun Park | Seo Yeon Hong | Young-Jung Roh
  • Special Issue
  • - Volume 2020
  • - Article ID 5839837
  • - Research Article

Choroidal Structural Changes Assessed with Swept-Source Optical Coherence Tomography after Cataract Surgery in Eyes with Diabetic Retinopathy

Huiping Yao | Sha Gao | ... | Xi Shen
  • Special Issue
  • - Volume 2020
  • - Article ID 9457457
  • - Research Article

Early Detection of Incipient Retinal Pigment Epithelium Atrophy Overlying Drusen with Fundus Autofluorescence vs. Spectral Domain Optical Coherence Tomography

Anabel Rodríguez | Marc Biarnés | ... | Jordi Monés
Journal of Ophthalmology
 Journal metrics
See full report
Acceptance rate10%
Submission to final decision129 days
Acceptance to publication18 days
CiteScore3.400
Journal Citation Indicator0.630
Impact Factor1.9
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.